Vecuronium (bromide) (Standard)

[1]Meretoja, O.A., Vecuronium infusion requirements in pediatric patients during fentanyl-N2O-O2 anesthesia. Anesth Analg, 1989. 68 (1) : p. 20-4.|[2]Agoston, S., et al., The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. Br J Anaesth, 1980. 52 Suppl 1: p. 53S-59S.|[3]Shingu, K., et al., [Neuromuscular blocking effects of Org 9426 (rocuronium bromide) ; a comparative study with vecuronium bromide in Japanese patients]. Masui, 2006. 55 (9) : p. 1140-8.|[4]K Uryu, et al. Inhibition by neuromuscular blocking drugs of norepinephrine transporter in cultured bovine adrenal medullary cells. Anesth Analg. 2000 Sep;91 (3) :546-51.|[5]Iddrisu BabaYabasin, et al. Anticancer effects of vecuronium bromide and cisatracurium besylate on lung cancer cells (A549), in vitro. Biomedicine & Aging Pathology, Volume 4, Issue 4, |[6]Ayuko Igarashi, et al. Vecuronium directly inhibits hypoxic neurotransmission of the rat carotid body. Anesth Analg. 2002 Jan;94 (1) :117-22, table of contents.